Biological active metabolites from microalgae for healthcare and pharmaceutical industries: A comprehensive review

Microalgae are photoautotrophic microorganisms which comprise of species from several phyla. Microalgae are promising in producing a varieties of products, including food, feed supplements, chemicals, and biofuels. Me-dicinal supplements derived from microalgae are of a significant market in which compounds such as-carotene, astaxanthin, polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and polysaccharides such as -glucan, are prominent. Microalgae species which are commonly applied for commercial productions include Isochrysis sp., Chaetoceros (Chlorella sp.), Arthrospira sp. (Spirulina Bioactive) and many more. In this present review, microalgae species which are feasible in metabolites production are being summarized. Metabolites produced by microalgae as well as their prospective applications in the healthcare and pharmaceutical industries, are comprehensively discussed. This evaluation is greatly assisting industrial stake-holders, investors, and researchers in making business decisions, investing in ventures, and moving the pro-duction of microalgae-based metabolites forward.

Automated summary

This review summarizes microalgae species capable of producing metabolites and comprehensively discusses the potential applications of these metabolites in the healthcare and pharmaceutical industries. It greatly assists industrial stakeholders, investors, and researchers in making business decisions, investing in ventures, and advancing the production of microalgae-based metabolites.